Fontan术后蛋白丢失性肠病的机制和治疗研究综述  

Protein-losing enteropathy after the Fontan operation:mechanisms andtherapies

作　　者：张家芬[1] 花中东[1] 沈向东[1] 

机构地区：[1]阜外心血管病医院小儿心外科,北京100037

出　　处：《中国分子心脏病学杂志》2009年第4期254-256,共3页Molecular Cardiology of China

摘　　要：蛋白丢失性肠病(PLE)是Fontan术后的并发症之一,Fontan术后出现PLE提示预后不良。目前无特异有效的治疗方法。本综述通过分析PLE的病理生理、肠系膜病理解剖、治疗有效病例的特征,探讨PLE发生的机制,分析Fontan术后出现PLE的危险因素并提出治疗建议。Protein-losing enteropathy （PLE） is one of the complications with significant morbidity and mortality seen after the Fontan operation. At present, there is no effective therapy for this complication. After summarizing the characteristics of the pathophysiology and the mesentery pathological anatomy of PLE after the Fontan procedure, especially the characteristics of the cases which responded well to certain therapies, to investigate the probable mechanisms, the risk factors of the incidence of PLE after the Fontan operation and to give treatment suggestions.

关 键 词：FONTAN手术 蛋白漏出性肠病(PLE) 机制 治疗方法 

分 类 号：R726.5[医药卫生—儿科]